Singer Nicholas Jason's Form 4 filing
Ernexa Therapeutics Inc. (ERNA) · filed Dec 6, 2022
- Accession no.
- 0001140361-22-044631
- Filed
- Dec 6, 2022, 6:52 PM ET
- Trade date
- Dec 2, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market purchases total $929.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Singer Nicholas JasonCIK 0001828224 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2022 | Common Stock | PPurchaseAcquired | +70,822 | $3.28 | +$232,296.16 | 121,822 | Indirect | |
| Dec 2, 2022 | Common Stock | PPurchaseAcquired | +212,464 | $3.28 | +$696,881.92 | 266,214 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2022 | Common Stock, par value $0.005 per share | PPurchaseAcquired | +141,644 | $0.125 | +$17,705.5 | 141,644 | Indirect | |
| Dec 2, 2022 | Common Stock, par value $0.005 per share | PPurchaseAcquired | +424,928 | $0.125 | +$53,116 | 424,928 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.